Webinar Date/Time: Wednesday, February 14th, 2024 at 11am EST | 8am PST | 4pm GMT | 5pm CET
Join us for an enlightening webinar as we explore the integration of AI, tech-enabled sites, enhanced patient engagement, and global delivery in the context of a diverse patient population. This immersive discussion will unpack the emerging trends and strategies that are revolutionizing clinical operations today through the lens of the patient, the site, and the sponsor around strategic patient recruitment, optimized site support, and the shift towards decentralized clinical trials.
Register Free: https://www.appliedclinicaltrialsonline.com/act/navigating-ai
Event overview
Join us as we explore the integration of AI, tech-enabled solutions, enhanced patient engagement, and the need to meet diversity and sustainability expectations in the context of a global clinical trial. This immersive discussion will unpack the emerging trends and strategies that are revolutionizing study design and delivery today through the lens of the patient, the site, and the sponsor to ensure strategic patient recruitment, optimized site support, and the shift towards decentralized and hybrid trial models.
Key takeaways
Speakers:
Alison Liddy
Vice President, Patient and Site Centric Solutions
IQVIA
Alison Liddy, Senior Vice President at IQVIA for Patient and Site Centric Solutions, thrives on variety and challenge. With a career spanning over 20 years in the healthcare and life sciences industry, she excels in overseeing large global teams, P&L management, revenue growth, and C-Suite Relationship Management. Alison's expertise extends to Digital & Change Transformation projects in the data and patient space within the Life Science industry. Passionate about creating efficient ways of working and utilizing technology to drive outcomes, she has held executive positions at ICON plc. and Accenture contributing significantly to their patient, site, and data strategy implementation that helped aide in accelerating drug delivery.
Murray Aitken
Executive Director
IQVIA Institute
Murray Aitken, Executive Director of the IQVIA Institute for Human Data Science, is a globally recognized authority in addressing challenges within the healthcare industry. With a rich 15-year history at IQVIA, he has seamlessly navigated diverse roles spanning healthcare insights, corporate strategy, and consulting. Previously, as a partner at McKinsey & Company in the U.S. and South Korea, with a focus on life sciences, Aitken brings extensive industry expertise. Holding a distinguished Harvard MBA and a Masters of Commerce from the University of Auckland, he is a sought-after speaker at international healthcare forums. Aitken's insightful perspectives grace esteemed publications including The Wall Street Journal, The Financial Times, Fortune, and CNBC.
Kerry Gorman
Sr. Director, Strategic Site Solutions
IQVIA
Kerry Gorman, Sr. Director of Strategic Site Solutions at IQVIA, brings a wealth of expertise in clinical research and customer service. Her current role as Head of IQVIA Strategic Site Solutions for the US and Canada showcases her adept leadership in fostering strong relationships with sites. Leading a dedicated team, Kerry's passion for addressing site concerns is evident. Drawing from her extensive background in pharmaceutical companies and innovative medical education communication ventures, Kerry's multifaceted career has uniquely positioned her to spearhead the IQVIA Prime and Partner site relationships program. Her nuanced understanding of the clinical research landscape makes her a pivotal asset in advancing IQVIA's strategic initiatives.
Katie Shaw
Global Head, Strategy and Product Development, Patient and Site Centric Solutions
IQVIA
Katie Shaw, is the driving force behind Strategy & Product Development for IQVIA’s Patient Recruitment and Enablement team, showcasing over 15 years of expertise in clinical research. Specializing in patient recruitment and engagement, her leadership spans data-driven strategy development, innovation in data science and technology, and seamless operational integration across global multi-disciplinary teams. Katie's influential role extends to operationalizing strategies and ensuring the adoption of IQVIA solutions. Her commitment to advancing patient-centric solutions and optimizing the intersection of data science, technology, and patient engagement underscores her dedication to shaping the future of clinical research.
Ann Dokus
Senior Director, Experience Optimization Patient Centric Solutions and Decentralized Trials
IQVIA
Ann Dokus, Senior Director of Experience Optimization, Patient Centric Solutions, and Decentralized Trials at IQVIA, is an accomplished Technology Innovator with a rich background in biopharmaceuticals, spanning big pharma (Pfizer) and boutique technology firms. Her robust skill set includes Business Planning, Operations Management, Clinical Research, IT Strategy, and Biotechnology. Ann's passion for patient centricity, user experience, Health IT, and the transformation of clinical trials defines her commitment to driving innovation and excellence in the dynamic intersection of technology and healthcare.
Denise Messer
Director, Design Analytics
IQVIA
Denise Messer, as the Director of Design Analytics at the IQVIA Applied Data Science Center, boasts a remarkable 25-year career in research and clinical trials. Her expertise spans clinical trial planning and design, and she's a distinguished speaker at conferences and contributor to industry journals. Messer's focus on patient-centric trial approaches is evident in her work on assessing patient burden and integrating the patient's voice into trial design. At IQVIA, she played a pivotal role in developing the innovative IQVIA Data-Informed Protocol Assessment, leveraging data to optimize protocols before implementation. Her contributions include creating a patient burden algorithm and establishing protocol scoring benchmarks, showcasing her commitment to advancing clinical trial efficiency.
Register Free: https://www.appliedclinicaltrialsonline.com/act/navigating-ai
What Can ClinOps Learn from Pre-Clinical?
August 10th 2021Dr. Hanne Bak, Senior Vice President of Preclinical Manufacturing and Process Development at Regeneron speaks about her role at the company as well as their work with monoclonal antibodies, the regulatory side of manufacturing, and more.
Moving Towards Decentralized Elements: Q&A with Scott Palmese, Worldwide Clinical Trials
December 6th 2024Palmese, executive director, site relationships and DCT solutions, discusses the practice of incorporating decentralized elements in a study rather than planning a decentralized trial from the start.
What Can ClinOps Learn from Pre-Clinical?
August 10th 2021Dr. Hanne Bak, Senior Vice President of Preclinical Manufacturing and Process Development at Regeneron speaks about her role at the company as well as their work with monoclonal antibodies, the regulatory side of manufacturing, and more.
Moving Towards Decentralized Elements: Q&A with Scott Palmese, Worldwide Clinical Trials
December 6th 2024Palmese, executive director, site relationships and DCT solutions, discusses the practice of incorporating decentralized elements in a study rather than planning a decentralized trial from the start.
2 Commerce Drive
Cranbury, NJ 08512